Global Upfront Newspapers
AmericaCoverHealthLifeNews

U.S. Commissions Country-funded Molecular Lab in FMC Makurdi

The U.S. Centres for Disease Control and Prevention (U.S. CDC) has commissioned the newly renovated molecular laboratory at Federal Medical Centre (FMC) Makurdi in Benue State.

The lab was renovated with funds and technical assistance from the U.S. CDC via the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).

The commissioning was conducted by the Acting Country Director Suzanne Theroux and Governor Hyacinth Alia of Benue State.

A statement by the U.S. Mission in Nigeria on Thursday said that “using state-of-the-art medical laboratory technology, the lab can now conduct HIV viral load and early infant diagnosis testing, as well as molecular tests for other priority diseases including tuberculosis, COVID-19, hepatitis, and HPV.”

In her remarks, Ms. Theroux stated that FMC Makurdi is now a model lab for the rest of Nigeria and commended their focus on quality management.

She added that “the high-quality data provided by the lab not only helps facilitate integrated service delivery for patients at healthcare facilities but also strengthens the state’s capacity to detect and quickly respond to disease threats.”

The statement adds that “FMC Makurdi currently tests more than 200,000 patient samples annually, making it one of the top molecular labs in the PEPFAR-Global Fund-supported molecular lab network.”

Advertize With Us

See Also

Pa Adebanjo: A Celebration Of Death

Global Upfront

Ouattara, Please Go

Global Upfront

Anti-Boko Haram Operations Was Politicised, Says CDS As Suleija Emir Laments Growing Army Of Terrorists, Bandits’ Informants

Global Upfront

Africans Must Learn To Control Their Own Resources

Global Upfront

‘I Am Here To Plunder’

Global Upfront

NDLEA Arrests Father Of 4 With 20.75kg Black Liquid Cocaine At Abuja Airport, Recovers 865.2kg drugs From Benin Republic; 30,880 Tramadol Tablets

Global Upfront

This website uses Cookies to improve User experience. We assume this is OK...If not, please opt-out! Accept Read More